These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8896773)
1. Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Strakowski SM; Sax KW; Setters MJ; Keck PE Biol Psychiatry; 1996 Nov; 40(9):872-80. PubMed ID: 8896773 [TBL] [Abstract][Full Text] [Related]
2. Lack of enhanced response to repeated d-amphetamine challenge in first-episode psychosis: implications for a sensitization model of psychosis in humans. Strakowski SM; Sax KW; Setters MJ; Stanton SP; Keck PE Biol Psychiatry; 1997 Nov; 42(9):749-55. PubMed ID: 9347122 [TBL] [Abstract][Full Text] [Related]
3. Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans. Strakowski SM; Sax KW Biol Psychiatry; 1998 Dec; 44(11):1171-7. PubMed ID: 9836021 [TBL] [Abstract][Full Text] [Related]
5. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Brauer LH; de Wit H Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123 [TBL] [Abstract][Full Text] [Related]
6. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults. Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936 [TBL] [Abstract][Full Text] [Related]
7. Effects of repeated doses of caffeine on mood and performance of alert and fatigued volunteers. Smith A; Sutherland D; Christopher G J Psychopharmacol; 2005 Nov; 19(6):620-6. PubMed ID: 16272184 [TBL] [Abstract][Full Text] [Related]
8. The neuroendocrine and behavioral response to dextroamphetamine in normal individuals. Dommisse CS; Schulz SC; Narasimhachari N; Blackard WG; Hamer RM Biol Psychiatry; 1984 Sep; 19(9):1305-15. PubMed ID: 6149772 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [TBL] [Abstract][Full Text] [Related]
10. Human response to repeated low-dose d-amphetamine: evidence for behavioral enhancement and tolerance. Strakowski SM; Sax KW; Rosenberg HL; DelBello MP; Adler CM Neuropsychopharmacology; 2001 Oct; 25(4):548-54. PubMed ID: 11557168 [TBL] [Abstract][Full Text] [Related]
14. Neuropsychological effects of amphetamine may correlate with personality characteristics. Fleming K; Bigelow LB; Weinberger DR; Goldberg TE Psychopharmacol Bull; 1995; 31(2):357-62. PubMed ID: 7491392 [TBL] [Abstract][Full Text] [Related]
15. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans. Parasrampuria DA; Schoedel KA; Schuller R; Gu J; Ciccone P; Silber SA; Sellers EM J Clin Pharmacol; 2007 Dec; 47(12):1476-88. PubMed ID: 17962423 [TBL] [Abstract][Full Text] [Related]
16. Individual differences in responses to ethanol and d-amphetamine: a within-subject study. Holdstock L; de Wit H Alcohol Clin Exp Res; 2001 Apr; 25(4):540-8. PubMed ID: 11329494 [TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo. Johanson CE; Kilbey M; Gatchalian K; Tancer M Drug Alcohol Depend; 2006 Jan; 81(1):27-36. PubMed ID: 15975736 [TBL] [Abstract][Full Text] [Related]
18. Single- and multiple-dose pharmacokinetics of an oral mixed amphetamine salts extended-release formulation in adults. Clausen SB; Read SC; Tulloch SJ CNS Spectr; 2005 Dec; 10(12 Suppl 20):6-15. PubMed ID: 16344836 [TBL] [Abstract][Full Text] [Related]
19. Repeated social-defeat stress, cocaine or morphine. Effects on behavioral sensitization and intravenous cocaine self-administration "binges". Covington HE; Miczek KA Psychopharmacology (Berl); 2001 Dec; 158(4):388-98. PubMed ID: 11797060 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers. Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]